DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

已收盘 01-08 16:00:00 EST

17.00

-0.99

-5.50%

盘后17.00

+0.000.00%

16:04 EST

最高18.03	最低16.80	成交量36.93万
今开17.94	昨收17.99	日振幅6.84%
总市值7.89亿	流通市值5.17亿	总股本4,643万
成交额637.80万	换手率1.21%	流通股本3,039万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":17,"timestamp":1767906000000,"preClose":17.99,"halted":0,"volume":369269,"hourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"16:04 EST","volume":1106,"amount":18802,"timestamp":1767906291056},"delay":0,"floatShares":30393100,"shares":46426600,"eps":-5.284455,"marketStatus":"已收盘","change":-0.99,"latestTime":"01-08 16:00:00 EST","open":17.94,"high":18.03,"low":16.8,"amount":6378034.477795,"amplitude":0.068371,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.284455,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767949200000},"marketStatusCode":5,"adr":1,"adrRate":5,"listingDate":1413950400000,"exchange":"NASDAQ","adjPreClose":17.99,"preHourTrading":{"tag":"盘前","latestPrice":17.94,"preClose":17.99,"latestTime":"09:29 EST","volume":1678,"amount":30244.33073,"timestamp":1767882599098},"postHourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"16:04 EST","volume":1106,"amount":18802,"timestamp":1767906291056},"volumeRatio":0.833738,"impliedVol":2.936,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2584670185","title":"Dbv Technologies盘中异动 早盘急速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584670185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584670185?lang=zh_cn&edition=full","pubTime":"2025-11-17 23:23","pubTimestamp":1763392993,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日23时23分，Dbv Technologies股票出现波动，股价急速上涨5.36%。截至发稿，该股报13.95美元/股，成交量4953股，换手率0.01%，振幅2.79%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.11%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117232313976f251c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117232313976f251c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2583072983","title":"Dbv Technologies盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583072983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583072983?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:33","pubTimestamp":1762957990,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时33分，Dbv Technologies股票出现异动，股价快速上涨5.26%。截至发稿，该股报14.04美元/股，成交量1.7001万股，换手率0.05%，振幅1.84%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.25%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223310a49caa67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223310a49caa67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2581011709","title":"Dbv Technologies盘中异动 早盘急速上涨7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581011709?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439601,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时33分，Dbv Technologies股票出现异动，股价急速上涨7.28%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Iovance Biotherapeutics, Inc.、Cytomed Therapeutics Limited、Pharming Group Nv涨幅较大，Osr Holdings, Inc.、Polyrizon Ltd.、Lunai Bioworks Inc.较为活跃，换手率分别为84.37%、11.27%、6.60%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Cartesian Therapeutics, Inc.、Sangamo Therapeutics, Inc.，振幅分别为20.60%、11.99%、11.78%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223321a6e63480&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223321a6e63480&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2581716188","title":"Dbv Technologies盘中异动 急速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581716188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581716188?lang=zh_cn&edition=full","pubTime":"2025-11-04 23:45","pubTimestamp":1762271100,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日23时45分，Dbv Technologies股票出现异动，股价急速拉升5.33%。截至发稿，该股报15.01美元/股，成交量1.2776万股，换手率0.04%，振幅6.16%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.36%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110423450094eee0bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110423450094eee0bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2578542189","title":"Dbv Technologies盘中异动 股价大涨5.43%报15.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578542189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578542189?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:54","pubTimestamp":1761317699,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日22时54分，Dbv Technologies股票出现波动，股价急速拉升5.43%。截至发稿，该股报15.67美元/股，成交量1.6891万股，换手率0.06%，振幅3.16%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.04%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。消息层面，截至22时55分，《LifeSci Capital维持DBV Technologies买入评级，维持目标价19美元》资讯为影响Dbv Technologies的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024225500a472fb04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024225500a472fb04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2572137025","title":"Dbv Technologies盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572137025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572137025?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:36","pubTimestamp":1759239360,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时36分，Dbv Technologies股票出现异动，股价急速拉升5.10%。截至发稿，该股报9.61美元/股，成交量3733股，换手率0.01%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.29%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213601a44eab98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213601a44eab98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2556338927","title":"Dbv Technologies盘中异动 股价大涨5.81%报9.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338927?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:22","pubTimestamp":1754320959,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时22分，Dbv Technologies股票出现波动，股价大幅拉升5.81%。截至发稿，该股报9.52美元/股，成交量5296股，换手率0.02%，振幅0.56%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804232240a6d2aabe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804232240a6d2aabe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2556826821","title":"Dbv Technologies2025财年第二财季实现净利润-42.40百万美元，同比减少28.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556826821","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556826821?lang=zh_cn&edition=full","pubTime":"2025-08-03 00:01","pubTimestamp":1754150493,"startTime":"0","endTime":"0","summary":"8月3日，Dbv Technologies公布财报，公告显示公司2025财年第二财季净利润为-42.40百万美元，同比减少28.02%；其中营业收入为0.00美元，每股基本收益为-1.58美元。从资产负债表来看，Dbv Technologies总负债57.21百万美元，其中短期债务7.89百万美元，资产负债比为0.03，流动比率为0.03。机构评级：截至2025年8月3日，当前有6家机构对Dbv Technologies目标价做出预测，其中目标均价为18.42美元，其中最低目标价为7.25美元，最高目标价为37.31美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000241a6cf788a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000241a6cf788a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT"],"gpt_icon":0},{"id":"2556832911","title":"Dbv Technologies盘中异动 急速拉升6.32%报9.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556832911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556832911?lang=zh_cn&edition=full","pubTime":"2025-07-31 23:58","pubTimestamp":1753977512,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日23时58分，Dbv Technologies股票出现波动，股价大幅拉升6.32%。截至发稿，该股报9.99美元/股，成交量4043股，换手率0.01%，振幅1.38%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为2.70%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073123583294c6a9d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073123583294c6a9d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2555743042","title":"Dbv Technologies盘中异动 大幅上涨5.41%报10.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555743042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555743042?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:33","pubTimestamp":1753882435,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时33分，Dbv Technologies股票出现波动，股价快速拉升5.41%。截至发稿，该股报10.33美元/股，成交量1635股，换手率0.01%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.56%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。公司正在开发的主要候选产品是用于治疗花生过敏患者的Viaskin Peanut。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213356a46bb560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213356a46bb560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2554772195","title":"Dbv Technologies盘中异动 股价大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772195?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:32","pubTimestamp":1753709532,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时32分，Dbv Technologies股票出现异动，股价急速拉升5.87%。截至发稿，该股报10.01美元/股，成交量4267股，换手率0.02%，振幅0.85%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.15%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213212a467d9be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213212a467d9be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2551492125","title":"Dbv Technologies盘中异动 急速跳水5.75%报9.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551492125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551492125?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:34","pubTimestamp":1752672884,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时34分，Dbv Technologies股票出现波动，股价大幅下跌5.75%。截至发稿，该股报9.58美元/股，成交量4752股，换手率0.02%，振幅0.98%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.83%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621344597a883a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621344597a883a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2551182813","title":"Dbv Technologies盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182813?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:41","pubTimestamp":1752500461,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时41分，Dbv Technologies股票出现异动，股价快速跳水5.42%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Dare Bioscience, Inc.、Promis Neurosciences Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1645.49%、419.01%、173.43%，振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Promis Neurosciences Inc.，振幅分别为97.01%、78.63%、56.35%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214101a6a8f41f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214101a6a8f41f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2518272635","title":"Dbv Technologies盘中异动 股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272635?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613459,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Dbv Technologies股票出现波动，股价快速上涨8.25%。截至发稿，该股报4.52美元/股，成交量4.8497万股，换手率0.24%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2517166262","title":"Dbv Technologies盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166262?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:51","pubTimestamp":1741272707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时51分，Dbv Technologies股票出现异动，股价快速跳水5.63%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.67%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2517910072","title":"Dbv Technologies盘中异动 股价大跌5.35%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910072?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185043,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dbv Technologies股票出现异动，股价大幅跳水5.35%。截至发稿，该股报4.07美元/股，成交量365股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2517098348","title":"Dbv Technologies盘中异动 下午盘大幅拉升8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517098348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517098348?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:49","pubTimestamp":1741117758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时49分，Dbv Technologies股票出现波动，股价大幅拉升8.33%。截至发稿，该股报4.29美元/股，成交量6073股，换手率0.03%，振幅5.05%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2516341226","title":"Dbv Technologies盘中异动 股价大跌8.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341226?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012404,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Dbv Technologies股票出现波动，股价急速跳水8.99%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.21%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2514202563","title":"Dbv Technologies盘中异动 早盘股价大跌6.43%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514202563?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:43","pubTimestamp":1740753830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时43分，Dbv Technologies股票出现异动，股价急速下挫6.43%。截至发稿，该股报3.93美元/股，成交量4017股，换手率0.02%，振幅0.41%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2513722215","title":"Dbv Technologies盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722215?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:41","pubTimestamp":1740408083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时41分，Dbv Technologies股票出现波动，股价大幅下挫5.35%。截至发稿，该股报4.16美元/股，成交量2295股，换手率0.01%，振幅0.91%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.06%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com","stockEarnings":[{"period":"1week","weight":-0.0616},{"period":"1month","weight":0.0595},{"period":"3month","weight":0.1336},{"period":"6month","weight":0.6657},{"period":"1year","weight":4.1844},{"period":"ytd","weight":-0.0616}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.该公司于2002年3月29日根据法兰西共和国法律注册成立。该公司是一家临床阶段的专业生物制药公司，专注于通过开发名为Viaskin的新型技术平台来改变免疫治疗领域。该公司的治疗方法基于表皮免疫疗法，即EPIT，这是其使用Viaskin通过完整皮肤向免疫系统递送生物活性化合物的专有方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.045441},{"month":2,"riseRate":0.545455,"avgChangeRate":0.001105},{"month":3,"riseRate":0.545455,"avgChangeRate":0.05101},{"month":4,"riseRate":0.636364,"avgChangeRate":0.094975},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.023241},{"month":6,"riseRate":0.363636,"avgChangeRate":0.035995},{"month":7,"riseRate":0.454545,"avgChangeRate":0.060449},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.030622},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.085227},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.114027},{"month":11,"riseRate":0.5,"avgChangeRate":0.015604},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01819}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}